Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Gland Pharma Ltd.
NSE: GLAND
|
BSE: 543245
|
ISIN: INE068V01023
|
Industry: Pharmaceuticals
Policy Impact
|
Strong Performer, Getting Expensive
2202.2000
4.60
(
0.21
%)
NSE
Jun 18, 2026
15:31 PM
39.95% Gain from 52W Low
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Gland Pharma Ltd.
29 Jan 2026
Policy Impact
2202.20
0.21%
Result Update:Gland Pharma
Buy:
Gland Pharma Ltd.
by
Axis Direct
Target: 2170 | Target met
Recommendation
Axis Direct
We maintain our BUY rating on the stock.
Number of FII/FPI investors decreased from 236 to 230 in Mar 2026 qtr
More from Gland Pharma Ltd.
Recommended
Market closes higher on lower oil prices and foreign fund inflows
Trendlyne Marketwatch |
18 Jun 2026, 04:03PM
India Inc tests the tolerance of consumers for higher prices
The Baseline |
18 Jun 2026, 10:54AM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
|
12 Nov 2020